Radan Džodić
Impact in
-
- Thyroid Cancer Diagnosis and Treatment
- Biotechnology top 5%
- Microbial Inactivation Methods
Papers in
-
- Thyroid Cancer Diagnosis and Treatment 35
-
- Breast Cancer Treatment Studies 10
- Co-authors
- Marko ButaIvan MarkovićZorka MilovanovićGordana KonjevićVladimir JurišićNada BabovićKatarina Mirjačić MartinovićGordana Pupić
In The Last Decade
Radan Džodić
82 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 94
- Endocrinology, Diabetes and Metabolism 293
- Biotechnology 99
- Oncology 295
- Hepatology 83
- Immunology 203
Countries citing papers authored by Radan Džodić
This map shows the geographic impact of Radan Džodić's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Radan Džodić with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Radan Džodić more than expected).
Fields of papers citing papers by Radan Džodić
This network shows the impact of papers produced by Radan Džodić. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Radan Džodić. The network helps show where Radan Džodić may publish in the future.
Co-authors
The 25 scholars most cited alongside Radan Džodić, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 1 | |
| 2 | Promoter hypermethylation of p16, BRCA1 and RASSF1A genes in triple-negative breast cancer patients from Serbia. | 2019 | 12 |
| 3 | 2019 | 4 | |
| 4 | 2018 | 8 | |
| 5 | 2015 | 8 | |
| 6 | 2015 | 13 | |
| 7 | 2015 | 12 | |
| 8 | 2015 | 37 | |
| 9 | 2014 | 46 | |
| 10 | 2014 | 13 | |
| 11 | 2014 | 46 | |
| 12 | PTEN protein expression in postmenopausal steroid receptor positive early breast cancer patients treated with adjuvant tamoxifen. | 2011 | 5 |
| 13 | 2011 | 25 | |
| 14 | 2010 | 16 | |
| 15 | 2004 | 2 | |
| 16 | 2004 | 70 | |
| 17 | 2003 | 1 | |
| 18 | 1998 | 96 | |
| 19 | 1997 | 9 | |
| 20 | 1996 | 24 |
About Radan Džodić
Radan Džodić is a scholar working on Endocrinology, Diabetes and Metabolism, Cancer Research, Oncology, Nephrology and Immunology, having authored 90 papers that have together received 1.0k indexed citations. Recurring topics across this work include Thyroid Cancer Diagnosis and Treatment (35 papers), Thyroid and Parathyroid Surgery (11 papers), Breast Cancer Treatment Studies (10 papers), BRCA gene mutations in cancer (9 papers), Head and Neck Anomalies (7 papers), Immunotherapy and Immune Responses (7 papers), Parathyroid Disorders and Treatments (5 papers) and Immune Cell Function and Interaction (5 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (293 citations), Biotechnology (99 citations), Oncology (295 citations), Hepatology (83 citations) and Immunology (203 citations). Radan Džodić has collaborated with scholars based in Serbia, Japan and Slovenia. Frequent co-authors include Marko Buta, Ivan Marković, Zorka Milovanović, Gordana Konjević, Vladimir Jurišić, Nada Babović, Katarina Mirjačić Martinović, Gordana Pupić, Nikola Tanić and Igor Djurisic. Their work appears in journals such as European Journal of Surgical Oncology, Journal of Clinical Oncology, BMC Cancer, World Journal of Surgery and Melanoma Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.